{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:31:53Z","timestamp":1788363113149,"version":"build-2803163510"},"reference-count":110,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA246304-05"],"award-info":[{"award-number":["R01 CA246304-05"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.cld.2024.12.003","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T12:37:35Z","timestamp":1740400655000},"page":"217-234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Role of Liver Transplant in Primary and Secondary Liver Malignancies"],"prefix":"10.1016","volume":"29","author":[{"given":"Andrew","family":"Melehy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vatche G.","family":"Agopian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cld.2024.12.003_bib1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/SLA.0b013e3182a15db4","article-title":"The evolution of liver transplantation during 3 decades: analysis of 5347 consecutive liver transplants at a single center","volume":"258","author":"Agopian","year":"2013","journal-title":"Ann Surg"},{"issue":"12","key":"10.1016\/j.cld.2024.12.003_bib2","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/tri.13358","article-title":"2018 annual report of the European Liver Transplant Registry (ELTR)\u201350-year evolution of liver transplantation","volume":"31","author":"Adam","year":"2018","journal-title":"Transpl Int"},{"issue":"2","key":"10.1016\/j.cld.2024.12.003_bib3","doi-asserted-by":"crossref","first-page":"S176","DOI":"10.1016\/j.ajt.2024.01.014","article-title":"OPTN\/SRTR 2022 annual data report: liver","volume":"24","author":"Kwong","year":"2024","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cld.2024.12.003_bib4","series-title":"Liver transplantation: an unfinished product","first-page":"2197","author":"Starzl","year":"1989"},{"issue":"5","key":"10.1016\/j.cld.2024.12.003_bib6","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/tri.13586","article-title":"Liver transplantation for hepatocellular carcinoma after successful treatment of macrovascular invasion\u2013a multi-center retrospective cohort study","volume":"33","author":"Assalino","year":"2020","journal-title":"Transpl Int"},{"issue":"4","key":"10.1016\/j.cld.2024.12.003_bib7","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jamcollsurg.2014.12.025","article-title":"A\u00a0novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients","volume":"220","author":"Agopian","year":"2015","journal-title":"J\u00a0Am Coll Surg"},{"issue":"11","key":"10.1016\/j.cld.2024.12.003_bib8","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.cld.2024.12.003_bib9","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1016\/j.ajt.2023.02.006","article-title":"OPTN\/SRTR 2021 annual data report: liver","volume":"23","author":"Kwong","year":"2023","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.cld.2024.12.003_bib10","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/lt.24955","article-title":"Current status of liver transplantation for cholangiocarcinoma","volume":"24","author":"Goldaracena","year":"2018","journal-title":"Liver Transplant"},{"key":"10.1016\/j.cld.2024.12.003_bib11","unstructured":"Guidance to Liver Transplantation Programs and the National Liver Review Board for: Adult MELD Exception Review, Available at: https:\/\/optn.transplant.hrsa.gov\/media\/2847\/liver_guidance_adult_meld_201706.pdf."},{"issue":"1","key":"10.1016\/j.cld.2024.12.003_bib12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.5662\/wjm.v12.i1.32","article-title":"Liver transplant allocation policies and outcomes in United States: a comprehensive review","volume":"12","author":"Latt","year":"2022","journal-title":"World J Methodol"},{"issue":"10360","key":"10.1016\/j.cld.2024.12.003_bib13","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.cld.2024.12.003_bib14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J Clin"},{"key":"10.1016\/j.cld.2024.12.003_bib15","first-page":"1","article-title":"Indication of liver transplant for HCC: current status and future directions","author":"Horwitz","year":"2024","journal-title":"Current Hepatology Reports"},{"issue":"1","key":"10.1016\/j.cld.2024.12.003_bib16","doi-asserted-by":"crossref","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA A Cancer J Clin"},{"issue":"5","key":"10.1016\/j.cld.2024.12.003_bib17","first-page":"738","article-title":"Hepatocellular carcinoma and the role of liver transplantation: a review","volume":"9","author":"Muhammad","year":"2021","journal-title":"J\u00a0Clin Transl Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2024.12.003_bib18","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/SLA.0000000000002889","article-title":"Liver transplantation and hepatic resection can achieve cure for hepatocellular carcinoma","volume":"268","author":"Pinna","year":"2018","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.cld.2024.12.003_bib19","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/SLA.0000000000002135","article-title":"Incidence of occult intrahepatic metastasis in hepatocellular carcinoma treated with transplantation corresponds to early recurrence rates after partial hepatectomy","volume":"267","author":"Aufhauser","year":"2018","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.cld.2024.12.003_bib20","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/SLA.0000000000000710","article-title":"Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis","volume":"261","author":"Tabrizian","year":"2015","journal-title":"Ann Surg"},{"issue":"S2","key":"10.1016\/j.cld.2024.12.003_bib21","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1002\/lt.22365","article-title":"Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience","volume":"17","author":"Mazzaferro","year":"2011","journal-title":"Liver Transplant"},{"issue":"1","key":"10.1016\/j.cld.2024.12.003_bib22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1470-2045(08)70284-5","article-title":"Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis","volume":"10","author":"Mazzaferro","year":"2009","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.cld.2024.12.003_bib23","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/hep.27787","article-title":"Total tumor volume and alpha-fetoprotein for selection of transplant candidates with hepatocellular carcinoma: a prospective validation","volume":"62","author":"Toso","year":"2015","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2024.12.003_bib24","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1053\/j.gastro.2017.09.025","article-title":"Metroticket 2.0 model for analysis of competing risks of death after liver transplantation for hepatocellular carcinoma","volume":"154","author":"Mazzaferro","year":"2018","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cld.2024.12.003_bib25","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1002\/hep.28643","article-title":"The extended Toronto criteria for liver transplantation in patients with hepatocellular carcinoma: a prospective validation study","volume":"64","author":"Sapisochin","year":"2016","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2024.12.003_bib26","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.surg.2013.04.056","article-title":"Usefulness of the Kyoto criteria as expanded selection criteria for liver transplantation for hepatocellular carcinoma","volume":"154","author":"Kaido","year":"2013","journal-title":"Surgery"},{"issue":"4","key":"10.1016\/j.cld.2024.12.003_bib27","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1053\/j.gastro.2012.05.052","article-title":"Liver transplantation for hepatocellular carcinoma: a model including \u03b1-fetoprotein improves the performance of Milan criteria","volume":"143","author":"Duvoux","year":"2012","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cld.2024.12.003_bib28","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/SLA.0000000000002964","article-title":"Is it time to abandon the Milan criteria?: results of a bicoastal US collaboration to redefine hepatocellular carcinoma liver transplantation selection policies","volume":"268","author":"Halazun","year":"2018","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.cld.2024.12.003_bib29","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1002\/hep.27752","article-title":"Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria","volume":"61","author":"Yao","year":"2015","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2024.12.003_bib30","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","volume":"78","author":"Singal","year":"2023","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.cld.2024.12.003_bib31","first-page":"779","article-title":"Ten-year outcomes of liver transplant and downstaging for hepatocellular carcinoma","volume":"157","author":"Tabrizian","year":"2022","journal-title":"JAMA surgery"},{"issue":"3","key":"10.1016\/j.cld.2024.12.003_bib32","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/hep.30879","article-title":"National experience on down-staging of hepatocellular carcinoma before liver transplant: influence of tumor burden, alpha-fetoprotein, and wait time","volume":"71","author":"Mehta","year":"2020","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2024.12.003_bib33","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/hep.30570","article-title":"Are there upper limits in tumor burden for down-staging of hepatocellular carcinoma to liver transplant? Analysis of the all-comers protocol","volume":"70","author":"Sinha","year":"2019","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2024.12.003_bib105","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.hbpd.2020.06.011","article-title":"Hangzhou criteria as downstaging criteria in hepatocellular carcinoma before liver transplantation: a multicenter study from China","volume":"19","author":"Zhan","year":"2020","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"6","key":"10.1016\/j.cld.2024.12.003_bib106","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1001\/jamasurg.2021.0954","article-title":"Dynamic \u03b1-fetoprotein response and outcomes after liver transplant for hepatocellular carcinoma","volume":"156","author":"Halazun","year":"2021","journal-title":"JAMA surgery"},{"issue":"2","key":"10.1016\/j.cld.2024.12.003_bib107","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/hep.30838","article-title":"Charting the path forward for risk prediction in liver transplant for hepatocellular carcinoma: international validation of HALTHCC among 4,089 patients","volume":"71","author":"Firl","year":"2020","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2024.12.003_bib108","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/SLA.0000000000001881","article-title":"A\u00a0novel prognostic index in patients with hepatocellular cancer waiting for liver transplantation: time-radiological-response-alpha-fetoprotein-INflammation (TRAIN) score","volume":"264","author":"Lai","year":"2016","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.cld.2024.12.003_bib34","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00432-021-03665-9","article-title":"Living donor liver transplantation for advanced hepatocellular carcinoma including macrovascular invasion","volume":"148","author":"Bhatti","year":"2022","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"issue":"1","key":"10.1016\/j.cld.2024.12.003_bib35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/lt.24610","article-title":"Macrovascular invasion is not an absolute contraindication for living donor liver transplantation","volume":"23","author":"Lee","year":"2017","journal-title":"Liver Transplant"},{"issue":"20","key":"10.1016\/j.cld.2024.12.003_bib36","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.cld.2024.12.003_bib37","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.3390\/cancers14071760","article-title":"Utilization of immunotherapy for the treatment of hepatocellular carcinoma in the peri-transplant setting: transplant oncology view","volume":"14","author":"Abdelrahim","year":"2022","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.cld.2024.12.003_bib38","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2024.05.037","article-title":"Immunotherapy for hepatocellular carcinoma: the next evolution in expanding access to liver transplantation","volume":"81","author":"Li","year":"2024","journal-title":"J\u00a0Hepatol"},{"issue":"10","key":"10.1016\/j.cld.2024.12.003_bib39","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.ajt.2024.04.007","article-title":"Pretransplant use of immune checkpoint inhibitors for hepatocellular carcinoma: a multicenter, retrospective cohort study","volume":"24","author":"Guo","year":"2024","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.cld.2024.12.003_bib40","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1111\/ajt.16448","article-title":"PD-1 inhibitor as bridge therapy to liver transplantation?","volume":"21","author":"Tabrizian","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cld.2024.12.003_bib41","series-title":"Evolution of liver transplant selection criteria and US allocation policy for patients with hepatocellular carcinoma","first-page":"358","author":"Heimbach","year":"2020"},{"issue":"8","key":"10.1016\/j.cld.2024.12.003_bib42","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1111\/j.1600-6143.2006.01411.x","article-title":"Reduced priority MELD score for hepatocellular carcinoma does not adversely impact candidate survival awaiting liver transplantation","volume":"6","author":"Sharma","year":"2006","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.cld.2024.12.003_bib43","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001313","article-title":"Early impact of MMaT-3 policy on liver transplant waitlist outcomes for hepatocellular carcinoma","volume":"8","author":"Shaikh","year":"2022","journal-title":"Transplantation Direct"},{"issue":"4","key":"10.1016\/j.cld.2024.12.003_bib44","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00000658-199610000-00005","article-title":"Cholangiocarcinoma: a spectrum of intrahepatic, perihilar, and distal tumors","volume":"224","author":"Nakeeb","year":"1996","journal-title":"Ann Surg"},{"key":"10.1016\/j.cld.2024.12.003_bib45","series-title":"Liver transplantation for cholangiocarcinoma. Diagnosis and management of cholangiocarcinoma: a multidisciplinary approach","first-page":"339","author":"Butler","year":"2021"},{"issue":"4","key":"10.1016\/j.cld.2024.12.003_bib46","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00000658-200110000-00010","article-title":"Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma","volume":"234","author":"Jarnagin","year":"2001","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.cld.2024.12.003_bib47","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1002\/hep.23600","article-title":"Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound","volume":"51","author":"Vilana","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2024.12.003_bib48","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/SLA.0b013e3182708b57","article-title":"Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections","volume":"258","author":"Nagino","year":"2013","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.cld.2024.12.003_bib49","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jhep.2019.10.009","article-title":"Systemic therapies for intrahepatic cholangiocarcinoma","volume":"72","author":"Kelley","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"8","key":"10.1016\/j.cld.2024.12.003_bib50","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1034\/j.1600-6143.2002.20812.x","article-title":"Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma","volume":"2","author":"Sudan","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cld.2024.12.003_bib51","series-title":"Liver transplantation for unresectable perihilar cholangiocarcinoma","first-page":"201","author":"Heimbach","year":"2004"},{"issue":"1","key":"10.1016\/j.cld.2024.12.003_bib52","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jamcollsurg.2012.03.014","article-title":"Neoadjuvant therapy and liver transplantation for hilar cholangiocarcinoma: is pretreatment pathological confirmation of diagnosis necessary?","volume":"215","author":"Rosen","year":"2012","journal-title":"J\u00a0Am Coll Surg"},{"issue":"3","key":"10.1016\/j.cld.2024.12.003_bib53","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/13651820801992542","article-title":"Surgery for cholangiocarcinoma: the role of liver transplantation","volume":"10","author":"Rosen","year":"2008","journal-title":"Hpb"},{"issue":"9","key":"10.1016\/j.cld.2024.12.003_bib54","first-page":"1675","article-title":"A\u00a0comparison of routine cytology and fluorescence in\u00a0situ hybridization for the detection of malignant bile duct strictures","volume":"99","author":"Kipp","year":"2004","journal-title":"ACG"},{"issue":"1","key":"10.1016\/j.cld.2024.12.003_bib55","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/hpb.12082","article-title":"Neoadjuvant chemoradiotherapy followed by liver transplantation for unresectable cholangiocarcinoma: a single-centre national experience","volume":"16","author":"Duignan","year":"2014","journal-title":"HPB"},{"issue":"5","key":"10.1016\/j.cld.2024.12.003_bib56","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/SLA.0000000000002574","article-title":"Transplantation versus resection for hilar cholangiocarcinoma: an argument for shifting treatment paradigms for resectable disease","volume":"267","author":"Ethun","year":"2018","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.cld.2024.12.003_bib65","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/lt.26285","article-title":"A\u00a03-decade, single-center experience of liver transplantation for cholangiocarcinoma: impact of era, tumor size, location, and neoadjuvant therapy","volume":"28","author":"Ito","year":"2022","journal-title":"Liver Transplant"},{"issue":"6","key":"10.1016\/j.cld.2024.12.003_bib64","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/archsurg.2011.116","article-title":"Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma: a 24-year experience in a single center","volume":"146","author":"Hong","year":"2011","journal-title":"Arch Surg"},{"issue":"4","key":"10.1016\/j.cld.2024.12.003_bib61","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/hep.28744","article-title":"Liver transplantation for \u201cvery early\u201d intrahepatic cholangiocarcinoma: international retrospective study supporting a prospective assessment","volume":"64","author":"Sapisochin","year":"2016","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2024.12.003_bib63","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S2468-1253(18)30045-1","article-title":"Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series","volume":"3","author":"Lunsford","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2024.12.003_bib62","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/lt.25737","article-title":"Analysis of liver resection versus liver transplantation on outcome of small intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma in the setting of cirrhosis","volume":"26","author":"De Martin","year":"2020","journal-title":"Liver Transplant"},{"issue":"3","key":"10.1016\/j.cld.2024.12.003_bib66","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/ajt.16906","article-title":"Survival following liver transplantation for locally advanced, unresectable intrahepatic cholangiocarcinoma","volume":"22","author":"McMillan","year":"2022","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1016\/j.cld.2024.12.003_bib57","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/lt.25807","article-title":"Comparison of wait-list mortality between cholangiocarcinoma and hepatocellular carcinoma liver transplant candidates","volume":"26","author":"Ziogas","year":"2020","journal-title":"Liver Transplant"},{"issue":"1","key":"10.1016\/j.cld.2024.12.003_bib58","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jhep.2019.03.013","article-title":"Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma","volume":"71","author":"Bertuccio","year":"2019","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2024.12.003_bib59","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/TP.0000000000003212","article-title":"Liver transplantation for cholangiocarcinoma and mixed hepatocellular cholangiocarcinoma: working group report from the ILTS transplant oncology consensus conference","volume":"104","author":"Sapisochin","year":"2020","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.cld.2024.12.003_bib60","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/ajt.12591","article-title":"\u201cVery early\u201d intrahepatic cholangiocarcinoma in cirrhotic patients: should liver transplantation be reconsidered in these patients?","volume":"14","author":"Sapisochin","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cld.2024.12.003_bib112","unstructured":"National Liver Review Board (NLRB) Updates Related to Transplant Oncology, Available at: https:\/\/optn.transplant.hrsa.gov\/media\/ymapp25j\/liver_nlrb_june-2024_pn.pdf."},{"issue":"5","key":"10.1016\/j.cld.2024.12.003_bib67","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1378\/chest.11-0039","article-title":"Clinical patterns and outcome in epithelioid hemangioendothelioma with or without pulmonary involvement: insights from an internet registry in the study of a rare cancer","volume":"140","author":"Lau","year":"2011","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.cld.2024.12.003_bib68","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1002\/cncr.22225","article-title":"Primary malignant hepatic epithelioid hemangioendothelioma: a comprehensive review of the literature with emphasis on the surgical therapy","volume":"107","author":"Mehrabi","year":"2006","journal-title":"Cancer"},{"issue":"Suppl 2","key":"10.1016\/j.cld.2024.12.003_bib69","first-page":"69","article-title":"Liver transplant for nonhepatocellular carcinoma malignancy","volume":"15","author":"Reyhan","year":"2017","journal-title":"Exp Clin Transplant"},{"issue":"3","key":"10.1016\/j.cld.2024.12.003_bib70","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/TP.0000000000001603","article-title":"Hepatic epithelioid hemangioendothelioma and adult liver transplantation: proposal for a prognostic score based on the analysis of the ELTR-ELITA registry","volume":"101","author":"Lai","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.cld.2024.12.003_bib71","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF03033723","article-title":"Fibrolamellar hepatocellular carcinoma in Mexican patients","volume":"8","author":"Arista-Nasr","year":"2002","journal-title":"Pathol Oncol Res"},{"issue":"2","key":"10.1016\/j.cld.2024.12.003_bib72","doi-asserted-by":"crossref","first-page":"755","DOI":"10.18632\/oncotarget.2712","article-title":"The genomic landscape of fibrolamellar hepatocellular carcinoma: whole genome sequencing of ten patients","volume":"6","author":"Darcy","year":"2015","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.cld.2024.12.003_bib73","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s11605-023-05621-z","article-title":"Treatment and prognosis of fibrolamellar hepatocellular carcinoma: a systematic review of the recent literature and meta-analysis","volume":"27","author":"Glavas","year":"2023","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"3","key":"10.1016\/j.cld.2024.12.003_bib74","doi-asserted-by":"crossref","first-page":"554","DOI":"10.21037\/jgo.2019.01.35","article-title":"Clinicopathological features and outcomes of fibrolamellar hepatocellular carcinoma","volume":"10","author":"Chakrabarti","year":"2019","journal-title":"J\u00a0Gastrointest Oncol"},{"issue":"3","key":"10.1016\/j.cld.2024.12.003_bib75","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/jso.24515","article-title":"Liver transplantation for fibrolamellar hepatocellular carcinoma: a national perspective","volume":"115","author":"Atienza","year":"2017","journal-title":"J\u00a0Surg Oncol"},{"issue":"6","key":"10.1016\/j.cld.2024.12.003_bib76","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/cncr.21703","article-title":"Outcome of patients with fibrolamellar hepatocellular carcinoma","volume":"106","author":"Stipa","year":"2006","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.cld.2024.12.003_bib77","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.jamcollsurg.2012.08.001","article-title":"A\u00a0systematic review: treatment and prognosis of patients with fibrolamellar hepatocellular carcinoma","volume":"215","author":"Mavros","year":"2012","journal-title":"J\u00a0Am Coll Surg"},{"issue":"4","key":"10.1016\/j.cld.2024.12.003_bib78","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000354698","article-title":"Prognostic indicators and treatment outcome in 94 cases of fibrolamellar hepatocellular carcinoma","volume":"85","author":"Kaseb","year":"2013","journal-title":"Oncology"},{"issue":"11","key":"10.1016\/j.cld.2024.12.003_bib79","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.hpb.2022.06.009","article-title":"Treatment strategies for neuroendocrine liver metastases: a systematic review","volume":"24","author":"Muttillo","year":"2022","journal-title":"HPB"},{"issue":"1","key":"10.1016\/j.cld.2024.12.003_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ecl.2010.12.005","article-title":"The epidemiology of gastroenteropancreatic neuroendocrine tumors","volume":"40","author":"Lawrence","year":"2011","journal-title":"Endocrinol Metabol Clin"},{"issue":"1","key":"10.1016\/j.cld.2024.12.003_bib81","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/MOT.0000000000001118","article-title":"Treating rare tumors with liver transplantation","volume":"29","author":"Melehy","year":"2024","journal-title":"Curr Opin Organ Transplant"},{"issue":"4","key":"10.1016\/j.cld.2024.12.003_bib82","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jhep.2007.07.004","article-title":"Neuroendocrine tumors metastatic to the liver: how to select patients for liver transplantation?","volume":"47","author":"Mazzaferro","year":"2007","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2024.12.003_bib83","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.surg.2017.05.006","article-title":"Liver transplantation in patients with liver metastases from neuroendocrine tumors: a systematic review","volume":"162","author":"Moris","year":"2017","journal-title":"Surgery"},{"issue":"10","key":"10.1016\/j.cld.2024.12.003_bib84","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1111\/ajt.13831","article-title":"The long-term benefit of liver transplantation for hepatic metastases from neuroendocrine tumors","volume":"16","author":"Mazzaferro","year":"2016","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1016\/j.cld.2024.12.003_bib85","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/archsurg.2011.186","article-title":"Liver transplantation for the treatment of liver metastases from neuroendocrine tumors: an analysis of the UNOS database","volume":"146","author":"Gedaly","year":"2011","journal-title":"Arch Surg"},{"issue":"1","key":"10.1016\/j.cld.2024.12.003_bib86","doi-asserted-by":"crossref","first-page":"42","DOI":"10.21037\/gs.2017.12.11","article-title":"Liver transplantation for unresectable pancreatic neuroendocrine tumors with liver metastases in an era of transplant oncology","volume":"7","author":"Shimata","year":"2018","journal-title":"Gland Surg"},{"issue":"5","key":"10.1016\/j.cld.2024.12.003_bib87","doi-asserted-by":"crossref","first-page":"708","DOI":"10.2967\/jnumed.115.163865","article-title":"Safety and efficacy of 68Ga-DOTATATE PET\/CT for diagnosis, staging, and treatment management of neuroendocrine tumors","volume":"57","author":"Deppen","year":"2016","journal-title":"J\u00a0Nucl Med"},{"issue":"5","key":"10.1016\/j.cld.2024.12.003_bib88","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1016\/j.cld.2024.12.003_bib89","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1001\/jama.2017.7630","article-title":"Colorectal cancer mortality rates in adults aged 20 to 54 Years in the United States, 1970-2014","volume":"318","author":"Siegel","year":"2017","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.cld.2024.12.003_bib90","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12885-017-3925-x","article-title":"Colorectal cancer liver metastases \u2013 a population-based study on incidence, management and survival","volume":"18","author":"Engstrand","year":"2018","journal-title":"BMC Cancer"},{"issue":"35","key":"10.1016\/j.cld.2024.12.003_bib91","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1200\/JCO.2008.17.7147","article-title":"Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741","volume":"26","author":"Sanoff","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.cld.2024.12.003_bib92","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/01.sla.0000217629.94941.cf","article-title":"Epidemiology and management of liver metastases from colorectal cancer","volume":"244","author":"Manfredi","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.cld.2024.12.003_bib93","first-page":"283","article-title":"Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors","volume":"4","author":"Kanas","year":"2012","journal-title":"Clin Epidemiol"},{"issue":"12","key":"10.1016\/j.cld.2024.12.003_bib94","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/j.1432-2277.2008.00735.x","article-title":"Liver transplantation for primary and metastatic liver cancers","volume":"21","author":"Hoti","year":"2008","journal-title":"Transpl Int"},{"issue":"8","key":"10.1016\/j.cld.2024.12.003_bib95","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/lt.24791","article-title":"Liver transplantation for colorectal liver metastasis: survival without recurrence can be achieved","volume":"23","author":"Toso","year":"2017","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1016\/j.cld.2024.12.003_bib96","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/SLA.0b013e3182823957","article-title":"Liver transplantation for nonresectable liver metastases from colorectal cancer","volume":"257","author":"Hagness","year":"2013","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.cld.2024.12.003_bib97","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/SLA.0000000000003404","article-title":"Survival following liver transplantation for patients with nonresectable liver-only colorectal metastases","volume":"271","author":"Dueland","year":"2020","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.cld.2024.12.003_bib98","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/SLA.0b013e3182823957","article-title":"Liver transplantation for nonresectable liver metastases from colorectal cancer","volume":"257","author":"Hagness","year":"2013","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.cld.2024.12.003_bib99","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/MOT.0000000000000977","article-title":"Liver transplantation for colorectal secondaries: on the way to validation","volume":"27","author":"Line","year":"2022","journal-title":"Curr Opin Organ Transplant"},{"issue":"2","key":"10.1016\/j.cld.2024.12.003_bib100","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/XCS.0000000000000734","article-title":"Toronto management of initially unresectable liver metastasis from colorectal cancer in a living donor liver transplant program","volume":"237","author":"Rajendran","year":"2023","journal-title":"J\u00a0Am Coll Surg"},{"issue":"4","key":"10.1016\/j.cld.2024.12.003_bib101","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.ajt.2023.09.001","article-title":"Living donor liver transplantation for colorectal cancer liver metastases: midterm outcomes at a single center in North America","volume":"24","author":"Kaltenmeier","year":"2024","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.cld.2024.12.003_bib102","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1001\/jamasurg.2022.0300","article-title":"Recipient and donor outcomes after living-donor liver transplant for unresectable colorectal liver metastases","volume":"157","author":"Hernandez-Alejandro","year":"2022","journal-title":"JAMA surgery"},{"issue":"10458","key":"10.1016\/j.cld.2024.12.003_bib103","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(24)01595-2","article-title":"Liver transplantation plus chemotherapy versus chemotherapy alone in patients with permanently unresectable colorectal liver metastases (TransMet): results from a multicentre, open-label, prospective, randomised controlled trial","volume":"404","author":"Adam","year":"2024","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.cld.2024.12.003_bib104","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/MOT.0000000000001142","article-title":"Expanding MELD exceptions for colorectal liver metastasis: data and policy","volume":"29","author":"Whitrock","year":"2024","journal-title":"Curr Opin Organ Transplant"},{"issue":"2","key":"10.1016\/j.cld.2024.12.003_bib109","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/SLA.0000000000003404","article-title":"Survival following liver transplantation for patients with nonresectable liver-only colorectal metastases","volume":"271","author":"Dueland","year":"2020","journal-title":"Ann Surg"},{"key":"10.1016\/j.cld.2024.12.003_bib110","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijsu.2020.03.078","article-title":"RAPID procedure for colorectal cancer liver metastasis","volume":"82","author":"Nadalin","year":"2020","journal-title":"Int J Surg"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326124001107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326124001107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T23:24:52Z","timestamp":1750375492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326124001107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":110,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1089326124001107"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2024.12.003","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of Liver Transplant in Primary and Secondary Liver Malignancies","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2024.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}